Why Regenerative Medicine Infrastructure Is Becoming a Global Economic Priority

Publisher name

World Economic Forum

Global investment in regenerative medicine infrastructure is increasingly framed as an economic and health system priority rather than a niche scientific endeavor. The article highlights how manufacturing capacity, skilled workforce development, regulatory readiness, and cross-border coordination are now critical bottlenecks for scaling cell and gene therapies worldwide. It positions infrastructure planning as essential to ensuring equitable access, supply resilience, and long-term sustainability of advanced therapies.

👉 Read the full article: Regenerative medicine infrastructure is becoming a global economic priority

Disclaimer

Images are illustrative only. This content does not provide medical advice. SSCTR is not responsible for clinical or regulatory decisions. The information is intended for educational and informational purposes only.